MiR-328 deregulation has been shown to promote BM in patients with NSCLC, partially by modulation of protein kinase C alpha (PRKCA), leading to high PRKCA levels and increased cancer cell migration [95]. Here, PRKCA is linked to non-small cell lung carcinoma.